Vanderbilt University

Dr. Peter Sordillo is a member of the Scientific Advisory Board of SignPath Pharma, a developmental stage biotechnology company that is studying liposomal curcumin, liposomes and other agents. Dr. Helson is CEO of SignPath Pharma. Laura Sordillo reports no conflicts. 4. Abstract Title: Paraptosis in human glioblastoma cell line induced by curcumin. ................
................